| Year |
Citation |
Score |
| 2024 |
Wooliscroft L, Salter A, Adusumilli G, Levasseur VA, Sun P, Lancia S, Perantie DC, Trinkaus K, Naismith RT, Song SK, Cross AH. Diffusion basis spectrum imaging and diffusion tensor imaging predict persistent black hole formation in multiple sclerosis. Multiple Sclerosis and Related Disorders. 84: 105494. PMID 38359694 DOI: 10.1016/j.msard.2024.105494 |
0.681 |
|
| 2023 |
Singer BA, Arnold DL, Drulovic J, Freedman MS, Gold R, Gudesblatt M, Jasinska E, LaGanke CC, Naismith RT, Negroski D, Oh J, Hernandez Perez MA, Selmaj K, Then Bergh F, Wundes A, et al. Diroximel fumarate in patients with relapsing-remitting multiple sclerosis: Final safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585231205708. PMID 37905526 DOI: 10.1177/13524585231205708 |
0.366 |
|
| 2023 |
Brier MR, Li Z, Ly M, Karim HT, Liang L, Du W, McCarthy JE, Cross AH, Benzinger TLS, Naismith RT, Chahin S. "Brain age" predicts disability accumulation in multiple sclerosis. Annals of Clinical and Translational Neurology. PMID 37119507 DOI: 10.1002/acn3.51782 |
0.674 |
|
| 2023 |
Brier MR, Xiang B, Ciotti JR, Chahin S, Wu GF, Naismith RT, Yablonskiy D, Cross AH. Quantitative MRI identifies lesional and non-lesional abnormalities in MOGAD. Multiple Sclerosis and Related Disorders. 73: 104659. PMID 37004272 DOI: 10.1016/j.msard.2023.104659 |
0.723 |
|
| 2022 |
Okuda DT, Kantarci O, Lebrun-Frénay C, Sormani MP, Azevedo CJ, Bovis F, Hua LH, Amezcua L, Mowry EM, Hotermans C, Mendoza J, Walsh JS, von Hehn C, Vargas WS, Donlon S, ... Naismith RT, et al. Dimethyl fumarate delays multiple sclerosis in radiologically isolated syndrome. Annals of Neurology. PMID 36401339 DOI: 10.1002/ana.26555 |
0.308 |
|
| 2022 |
Ontaneda D, Mowry EM, Newsome SD, Naismith RT, Nicholas J, Fisher E, de Moor C, Bohn J, Ho PR, Sandrock A, Rudick R, Williams JR. Benefits of early treatment with natalizumab: a real-world study. Multiple Sclerosis and Related Disorders. 68: 104216. PMID 36288658 DOI: 10.1016/j.msard.2022.104216 |
0.36 |
|
| 2022 |
Naismith RT, Cross AH. Further support for rituximab in relapsing multiple sclerosis. The Lancet. Neurology. 21: 672-673. PMID 35841895 DOI: 10.1016/S1474-4422(21)00180-0 |
0.697 |
|
| 2022 |
Ryerson LZ, Naismith RT, Krupp LB, Charvet LE, Liao S, Fisher E, de Moor C, Williams JR, Campbell N. No difference in radiologic outcomes for natalizumab patients treated with extended interval dosing compared with standard interval dosing: Real-world evidence from MS PATHS. Multiple Sclerosis and Related Disorders. 58: 103480. PMID 35051898 DOI: 10.1016/j.msard.2021.103480 |
0.356 |
|
| 2021 |
Solomon AJ, Kaisey M, Krieger SC, Chahin S, Naismith RT, Weinstein SM, Shinohara RT, Weinshenker BG. Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211048401. PMID 34612110 DOI: 10.1177/13524585211048401 |
0.313 |
|
| 2021 |
Gray-Roncal K, Fitzgerald K, Ryerson LZ, Charvet L, Cassard SD, Naismith R, Ontaneda D, Mahajan K, Castro-Borrero W, Mowry E. Association of Disease Severity and Socioeconomic Status in Black and White Americans With Multiple Sclerosis. Neurology. PMID 34193590 DOI: 10.1212/WNL.0000000000012362 |
0.333 |
|
| 2021 |
Brier MR, Snyder AZ, Tanenbaum A, Rudick RA, Fisher E, Jones S, Shimony JS, Cross AH, Benzinger TLS, Naismith RT. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability. Annals of Clinical and Translational Neurology. PMID 33943045 DOI: 10.1002/acn3.51354 |
0.714 |
|
| 2021 |
Cross AH, Naismith RT. MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses - No. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211001564. PMID 33874812 DOI: 10.1177/13524585211001564 |
0.684 |
|
| 2021 |
Ciotti JR, Eby NS, Brier MR, Wu GF, Chahin S, Cross AH, Naismith RT. Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica. Multiple Sclerosis (Houndmills, Basingstoke, England). 13524585211007086. PMID 33870786 DOI: 10.1177/13524585211007086 |
0.661 |
|
| 2021 |
Wundes A, Wray S, Gold R, Singer BA, Jasinska E, Ziemssen T, de Seze J, Repovic P, Chen H, Hanna J, Messer J, Miller C, Naismith RT. Improved gastrointestinal profile with diroximel fumarate is associated with a positive impact on quality of life compared with dimethyl fumarate: results from the randomized, double-blind, phase III EVOLVE-MS-2 study. Therapeutic Advances in Neurological Disorders. 14: 1756286421993999. PMID 33796143 DOI: 10.1177/1756286421993999 |
0.322 |
|
| 2021 |
Fox RJ, Raska P, Barro C, Karafa M, Konig V, Bermel RA, Chase M, Coffey CS, Goodman AD, Klawiter EC, Naismith RT, Kuhle J. Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520986956. PMID 33635141 DOI: 10.1177/1352458520986956 |
0.701 |
|
| 2021 |
Goodman AD, Fedler JK, Yankey J, Klingner EA, Ecklund DJ, Goebel CV, Bermel RA, Chase M, Coffey CS, Klawiter EC, Naismith RT, Fox RJ. Response to ibudilast treatment according to progressive multiple sclerosis disease phenotype. Annals of Clinical and Translational Neurology. 8: 111-118. PMID 33460301 DOI: 10.1002/acn3.51251 |
0.67 |
|
| 2020 |
Naismith RT, Bermel RA, Coffey CS, Goodman AD, Fedler J, Kearney M, Klawiter EC, Nakamura K, Narayanan S, Goebel C, Yankey J, Klingner E, Fox RJ. Effects of ibudilast on MRI measures in the phase 2 SPRINT-MS study. Neurology. PMID 33268562 DOI: 10.1212/WNL.0000000000011314 |
0.7 |
|
| 2020 |
Bermel RA, Fedler JK, Kaiser P, Novalis C, Schneebaum J, Klingner EA, Williams D, Yankey JW, Ecklund DJ, Chase M, Naismith RT, Klawiter EC, Goodman AD, Coffey CS, Fox RJ. Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458520964409. PMID 33054533 DOI: 10.1177/1352458520964409 |
0.698 |
|
| 2020 |
Mowry EM, Bermel RA, Williams JR, Benzinger TLS, de Moor C, Fisher E, Hersh CM, Hyland MH, Izbudak I, Jones SE, Kieseier BC, Kitzler HH, Krupp L, Lui YW, Montalban X, ... Naismith RT, et al. Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS). Frontiers in Neurology. 11: 632. PMID 32849170 DOI: 10.3389/Fneur.2020.00632 |
0.395 |
|
| 2020 |
Plotnik M, Wagner JM, Adusumilli G, Gottlieb A, Naismith RT. Gait asymmetry, and bilateral coordination of gait during a six-minute walk test in persons with multiple sclerosis. Scientific Reports. 10: 12382. PMID 32709914 DOI: 10.1038/s41598-020-68263-0 |
0.306 |
|
| 2020 |
Ciotti JR, Eby NS, Wu GF, Naismith RT, Chahin S, Cross AH. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica. Multiple Sclerosis and Related Disorders. 45: 102399. PMID 32702642 DOI: 10.1016/J.Msard.2020.102399 |
0.678 |
|
| 2020 |
Ye Z, George A, Wu AT, Niu X, Lin J, Adusumilli G, Naismith RT, Cross AH, Sun P, Song SK. Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions. Annals of Clinical and Translational Neurology. PMID 32304291 DOI: 10.1002/Acn3.51037 |
0.688 |
|
| 2020 |
Sun P, George A, Perantie DC, Trinkaus K, Ye Z, Naismith RT, Song SK, Cross AH. Diffusion basis spectrum imaging provides insights into MS pathology. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 31871296 DOI: 10.1212/Nxi.0000000000000655 |
0.699 |
|
| 2019 |
Sormani MP, Naismith RT. Measuring disability in multiple sclerosis: Walking plus much more. Neurology. 93: 919-920. PMID 31641015 DOI: 10.1212/WNL.0000000000008515 |
0.333 |
|
| 2019 |
Shirani A, Sun P, Trinkaus K, Perantie DC, George A, Naismith RT, Schmidt RE, Song SK, Cross AH. Diffusion basis spectrum imaging for identifying pathologies in MS subtypes. Annals of Clinical and Translational Neurology. PMID 31588688 DOI: 10.1002/Acn3.50903 |
0.722 |
|
| 2019 |
Matza LS, Stewart KD, Phillips G, Delio P, Naismith RT. Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS). Multiple Sclerosis and Related Disorders. 35: 253-261. PMID 31437740 DOI: 10.1016/j.msard.2019.06.024 |
0.318 |
|
| 2019 |
Haider L, Naismith RT, Rovira A. Use of gadolinium for MRI diagnostic or surveillance studies in patients with MS. Neurology. PMID 31285397 DOI: 10.1212/WNL.0000000000007891 |
0.365 |
|
| 2019 |
Shirani A, Cross AH, Naismith RT. The association between handedness and clinicodemographic characteristics in people with multiple sclerosis: a brief report. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 5: 2055217319832031. PMID 30834138 DOI: 10.1177/2055217319832031 |
0.66 |
|
| 2019 |
Wolinsky J, Brochet B, Hartung H, Naismith R, Airas L, Coutant K, Koendgen H, Manfrini M, Mehta L, Prajapati K, Kappos L. Sustained reduction in confirmed disability progression after 6.5 study-years of ocrelizumab treatment in patients with primary progressive multiple sclerosis Journal of the Neurological Sciences. 405: 31. DOI: 10.1016/J.Jns.2019.10.269 |
0.303 |
|
| 2018 |
Solomon AJ, Naismith RT, Cross AH. Misdiagnosis of multiple sclerosis: Impact of the 2017 McDonald criteria on clinical practice. Neurology. PMID 30381369 DOI: 10.1212/Wnl.0000000000006583 |
0.702 |
|
| 2018 |
Zivadinov R, Medin J, Khan N, Korn JR, Chitnis T, Naismith RT, Alvarez E, Dwyer MG, Bergsland N, Carl E, Silva D, Weinstock-Guttman B. Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study. Multiple Sclerosis and Related Disorders. 27: 65-73. PMID 30342416 DOI: 10.1016/J.Msard.2018.09.037 |
0.554 |
|
| 2018 |
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, et al. Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. The New England Journal of Medicine. 379: 846-855. PMID 30157388 DOI: 10.1056/Nejmoa1803583 |
0.727 |
|
| 2018 |
Shirani A, Sun P, Schmidt RE, Trinkaus K, Naismith RT, Song SK, Cross AH. Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: A brief report. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518786072. PMID 29992856 DOI: 10.1177/1352458518786072 |
0.684 |
|
| 2018 |
Zivadinov R, Medin J, Khan N, Korn JR, Bergsland N, Dwyer MG, Chitnis T, Naismith RT, Alvarez E, Kinkel P, Cohan S, Hunter SF, Silva D, Weinstock-Guttman B. Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 29749661 DOI: 10.1111/Jon.12518 |
0.606 |
|
| 2017 |
Cross AH, Naismith RT. Refining the use of MRI to predict multiple sclerosis. The Lancet. Neurology. PMID 29275978 DOI: 10.1016/S1474-4422(17)30459-3 |
0.654 |
|
| 2017 |
Adusumilli G, Trinkaus K, Sun P, Lancia S, Viox JD, Wen J, Naismith RT, Cross AH. Intensity ratio to improve black hole assessment in multiple sclerosis. Multiple Sclerosis and Related Disorders. 19: 140-147. PMID 29223871 DOI: 10.1016/J.Msard.2017.11.020 |
0.641 |
|
| 2017 |
Toosy AT, Naismith RT, Villoslada P. OCT as a window to the MS brain: The view becomes slightly clearer. Neurology. PMID 29142085 DOI: 10.1212/WNL.0000000000004755 |
0.325 |
|
| 2017 |
Baldassari LE, Salter AR, Longbrake EE, Cross AH, Naismith RT. Streamlined EDSS for use in multiple sclerosis clinical practice: Development and cross-sectional comparison to EDSS. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458517721357. PMID 28766993 DOI: 10.1177/1352458517721357 |
0.638 |
|
| 2017 |
Clerico M, De Mercanti S, Artusi CA, Durelli L, Naismith RT. Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458516688350. PMID 28290755 DOI: 10.1177/1352458516688350 |
0.303 |
|
| 2016 |
Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, et al. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology. PMID 27581217 DOI: 10.1212/Wnl.0000000000003152 |
0.717 |
|
| 2015 |
Alvarez E, Piccio L, Mikesell RJ, Trinkaus K, Parks BJ, Naismith RT, Cross AH. Predicting optimal response to B-cell depletion with rituximab in multiple sclerosis using CXCL13 index, magnetic resonance imaging and clinical measures. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1: 2055217315623800. PMID 28607711 DOI: 10.1177/2055217315623800 |
0.775 |
|
| 2015 |
Longbrake EE, Naismith RT, Parks BJ, Wu GF, Cross AH. Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 1. PMID 26550483 DOI: 10.1177/2055217315596994 |
0.689 |
|
| 2015 |
Naismith RT, Cross AH. Enhancing our understanding of white matter changes in early multiple sclerosis. Brain : a Journal of Neurology. 138: 2465-6. PMID 26304148 DOI: 10.1093/Brain/Awv196 |
0.677 |
|
| 2015 |
Bermel RA, Naismith RT. Using MRI to make informed clinical decisions in multiple sclerosis care. Current Opinion in Neurology. 28: 244-9. PMID 25887772 DOI: 10.1097/WCO.0000000000000204 |
0.306 |
|
| 2015 |
Wang Y, Sun P, Wang Q, Trinkaus K, Schmidt RE, Naismith RT, Cross AH, Song SK. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Brain : a Journal of Neurology. 138: 1223-38. PMID 25724201 DOI: 10.1093/Brain/Awv046 |
0.698 |
|
| 2014 |
Naismith RT, Cross AH. Antisense therapy: potential tool to reduce activity in MS via protein expression inhibition. Neurology. 83: 1776-7. PMID 25239837 DOI: 10.1212/Wnl.0000000000000927 |
0.606 |
|
| 2014 |
Giovannoni G, Naismith RT. Natalizumab to fingolimod washout in patients at risk of PML: when good intentions yield bad outcomes. Neurology. 82: 1196-7. PMID 24610331 DOI: 10.1212/WNL.0000000000000296 |
0.301 |
|
| 2014 |
Wagner JM, Kremer TR, Van Dillen LR, Naismith RT. Plantarflexor weakness negatively impacts walking in persons with multiple sclerosis more than plantarflexor spasticity. Archives of Physical Medicine and Rehabilitation. 95: 1358-65. PMID 24582617 DOI: 10.1016/j.apmr.2014.01.030 |
0.355 |
|
| 2014 |
Cross AH, Naismith RT. Established and novel disease-modifying treatments in multiple sclerosis. Journal of Internal Medicine. 275: 350-63. PMID 24444048 DOI: 10.1111/Joim.12203 |
0.691 |
|
| 2013 |
Fenoglio C, Ridolfi E, Cantoni C, De Riz M, Bonsi R, Serpente M, Villa C, Pietroboni AM, Naismith RT, Alvarez E, Parks BJ, Bresolin N, Cross AH, Piccio LM, Galimberti D, et al. Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1938-42. PMID 24277735 DOI: 10.1177/1352458513485654 |
0.769 |
|
| 2013 |
Naismith RT, Xu J, Klawiter EC, Lancia S, Tutlam NT, Wagner JM, Qian P, Trinkaus K, Song SK, Cross AH. Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease. Neurology. 80: 2201-9. PMID 23667060 DOI: 10.1212/Wnl.0B013E318296E8F1 |
0.762 |
|
| 2013 |
Alvarez E, Piccio L, Mikesell RJ, Klawiter EC, Parks BJ, Naismith RT, Cross AH. CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1204-8. PMID 23322500 DOI: 10.1177/1352458512473362 |
0.787 |
|
| 2013 |
Xu J, Shimony JS, Klawiter EC, Snyder AZ, Trinkaus K, Naismith RT, Benzinger TL, Cross AH, Song SK. Improved in vivo diffusion tensor imaging of human cervical spinal cord. Neuroimage. 67: 64-76. PMID 23178538 DOI: 10.1016/J.Neuroimage.2012.11.014 |
0.746 |
|
| 2012 |
Cook SD, Dhib-Jalbut S, Dowling P, Durelli L, Ford C, Giovannoni G, Halper J, Harris C, Herbert J, Li D, Lincoln JA, Lisak R, Lublin FD, Lucchinetti CF, Moore W, ... Naismith RT, et al. Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010. International Journal of Ms Care. 14: 105-14. PMID 24453741 DOI: 10.7224/1537-2073-14.3.105 |
0.428 |
|
| 2012 |
Qian P, Lancia S, Alvarez E, Klawiter EC, Cross AH, Naismith RT. Association of neuromyelitis optica with severe and intractable pain. Archives of Neurology. 69: 1482-7. PMID 22926050 DOI: 10.1001/Archneurol.2012.768 |
0.77 |
|
| 2012 |
Khanna S, Sharma A, Huecker J, Gordon M, Naismith RT, Van Stavern GP. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society. 32: 216-20. PMID 22659839 DOI: 10.1097/WNO.0b013e318254c62d |
0.39 |
|
| 2012 |
Klawiter EC, Xu J, Naismith RT, Benzinger TL, Shimony JS, Lancia S, Snyder AZ, Trinkaus K, Song SK, Cross AH. Increased radial diffusivity in spinal cord lesions in neuromyelitis optica compared with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 18: 1259-68. PMID 22354742 DOI: 10.1177/1352458512436593 |
0.796 |
|
| 2012 |
Naismith RT, Xu J, Tutlam NT, Lancia S, Trinkaus K, Song SK, Cross AH. Diffusion tensor imaging in acute optic neuropathies: predictor of clinical outcomes. Archives of Neurology. 69: 65-71. PMID 21911658 DOI: 10.1001/Archneurol.2011.243 |
0.662 |
|
| 2012 |
Qian P, Cross A, Naismith R. Pain in Neuromyelitis Optica Is More Common, Disabling, and Refractory Compared to MS (P07.070) Neurology. 78: P07.070-P07.070. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P07.070 |
0.621 |
|
| 2012 |
Qian P, Lancia S, Patnaik R, Xu J, Cross A, Wolansky L, Cook S, Cadavid D, Naismith R. Ring-Enhancing Lesions in MS: Longitudinal Quantification by Diffusion Tensor and Magnetization Transfer Imaging (P03.039) Neurology. 78: P03.039-P03.039. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P03.039 |
0.68 |
|
| 2011 |
Naismith RT. Multiple sclerosis therapeutic strategies: Start safe and effective, reassess early, and escalate if necessary. Neurology. Clinical Practice. 1: 69-72. PMID 23634357 DOI: 10.1212/CPJ.0b013e31823cc2b0 |
0.303 |
|
| 2011 |
Qian P, Cross AH, Naismith RT. Lack of response to monoclonal antibody therapy in neuromyelitis optica. Archives of Neurology. 68: 1207-9. PMID 21911704 DOI: 10.1001/Archneurol.2011.194 |
0.618 |
|
| 2011 |
Klawiter EC, Schmidt RE, Trinkaus K, Liang HF, Budde MD, Naismith RT, Song SK, Cross AH, Benzinger TL. Radial diffusivity predicts demyelination in ex vivo multiple sclerosis spinal cords. Neuroimage. 55: 1454-60. PMID 21238597 DOI: 10.1016/J.Neuroimage.2011.01.007 |
0.789 |
|
| 2010 |
Klawiter EC, Benzinger T, Roy A, Naismith RT, Parks BJ, Cross AH. Spinal cord ring enhancement in multiple sclerosis. Archives of Neurology. 67: 1395-8. PMID 21060017 DOI: 10.1001/Archneurol.2010.271 |
0.756 |
|
| 2010 |
Piccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH. Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Archives of Neurology. 67: 707-14. PMID 20558389 DOI: 10.1001/Archneurol.2010.99 |
0.734 |
|
| 2010 |
Naismith RT, Piccio L, Lyons JA, Lauber J, Tutlam NT, Parks BJ, Trinkaus K, Song SK, Cross AH. Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial. Neurology. 74: 1860-7. PMID 20530322 DOI: 10.1212/Wnl.0B013E3181E24373 |
0.779 |
|
| 2010 |
Naismith RT, Xu J, Tutlam NT, Trinkaus K, Cross AH, Song SK. Radial diffusivity in remote optic neuritis discriminates visual outcomes. Neurology. 74: 1702-10. PMID 20498438 DOI: 10.1212/Wnl.0B013E3181E0434D |
0.592 |
|
| 2010 |
Naismith RT, Xu J, Tutlam NT, Scully PT, Trinkaus K, Snyder AZ, Song SK, Cross AH. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology. 74: 1694-701. PMID 20498437 DOI: 10.1212/Wnl.0B013E3181E042C4 |
0.655 |
|
| 2010 |
De Riz M, Galimberti D, Fenoglio C, Piccio LM, Scalabrini D, Venturelli E, Pietroboni A, Piola M, Naismith RT, Parks BJ, Fumagalli G, Bresolin N, Cross AH, Scarpini E. Cerebrospinal fluid progranulin levels in patients with different multiple sclerosis subtypes. Neuroscience Letters. 469: 234-6. PMID 19963041 DOI: 10.1016/J.Neulet.2009.12.002 |
0.773 |
|
| 2009 |
Klawiter EC, Cross AH, Naismith RT. The present efficacy of multiple sclerosis therapeutics: Is the new 66% just the old 33%? Neurology. 73: 984-90. PMID 19770475 DOI: 10.1212/Wnl.0B013E3181B9C8F7 |
0.773 |
|
| 2009 |
Naismith RT, Shepherd JB, Weihl CC, Tutlam NT, Cross AH. Acute and bilateral blindness due to optic neuropathy associated with copper deficiency. Archives of Neurology. 66: 1025-7. PMID 19667226 DOI: 10.1001/Archneurol.2009.70 |
0.596 |
|
| 2009 |
Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, Cross AH. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology. 73: 46-52. PMID 19564583 DOI: 10.1212/Wnl.0B013E3181Aaea32 |
0.725 |
|
| 2009 |
Klawiter EC, Alvarez E, Xu J, Paciorkowski AR, Zhu L, Parks BJ, Cross AH, Naismith RT. NMO-IgG detected in CSF in seronegative neuromyelitis optica. Neurology. 72: 1101-3. PMID 19307546 DOI: 10.1212/01.Wnl.0000345066.57745.50 |
0.773 |
|
| 2009 |
Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, Song SK, Cross AH. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology. 72: 1077-82. PMID 19307541 DOI: 10.1212/01.Wnl.0000345042.53843.D5 |
0.779 |
|
| 2009 |
Naismith RT, Xu J, Tutlam NT, Snyder A, Benzinger T, Shimony J, Shepherd J, Trinkaus K, Cross AH, Song SK. Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology. 72: 589-94. PMID 19073948 DOI: 10.1212/01.wnl.0000335766.22758.cd |
0.623 |
|
| 2008 |
Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker J, Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M, Cross AH. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain : a Journal of Neurology. 131: 3081-91. PMID 18790823 DOI: 10.1093/Brain/Awn217 |
0.817 |
|
| 2008 |
Xu J, Sun SW, Naismith RT, Snyder AZ, Cross AH, Song SK. Assessing optic nerve pathology with diffusion MRI: from mouse to human. Nmr in Biomedicine. 21: 928-40. PMID 18756587 DOI: 10.1002/Nbm.1307 |
0.629 |
|
| 2007 |
Rinker JR, Trinkaus K, Naismith RT, Cross AH. Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. Neurology. 69: 68-72. PMID 17606883 DOI: 10.1212/01.Wnl.0000265057.79843.D9 |
0.749 |
|
| 2007 |
Naismith RT, Cross AH. Magnetic resonance imaging of multiple sclerosis Continuum Lifelong Learning in Neurology. 13: 117-143. DOI: 10.1212/01.CON.0000293643.43858.9a |
0.63 |
|
| 2007 |
Benzinger TLS, Cross AH, Xu J, Naismith R, Sun SW, Song SK. Directional diffusivity as a magnetic resonance (MR) biomarker in demyelinating disease Proceedings of Spie - the International Society For Optical Engineering. 6759. DOI: 10.1117/12.740133 |
0.617 |
|
| 2006 |
Naismith RT, Trinkaus K, Cross AH. Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review. Multiple Sclerosis (Houndmills, Basingstoke, England). 12: 775-81. PMID 17263006 DOI: 10.1177/1352458506070923 |
0.706 |
|
| 2005 |
Naismith RT, Cross AH. Multiple sclerosis and black holes: connecting the pixels. Archives of Neurology. 62: 1666-8. PMID 16286537 DOI: 10.1001/Archneur.62.11.1666 |
0.633 |
|
| 2004 |
Naismith RT, Cross AH. Does the hepatitis B vaccine cause multiple sclerosis? Neurology. 63: 772-3. PMID 15365121 DOI: 10.1212/01.Wnl.0000137887.24504.30 |
0.657 |
|
| 2001 |
Naismith RT, Cross AH. Multiple sclerosis: Current treatment and future therapeutic directions Neuroscience News. 4: 48-57. |
0.644 |
|
| Show low-probability matches. |